Vertex Pharmaceuticals (VRTX) Free Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.71% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.65% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 31.42% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.71% |
| Dec 31, 2025 | -30.64% |
| Sep 30, 2025 | 8.13% |
| Jun 30, 2025 | -5.14% |
| Mar 31, 2025 | -4.47% |
| Dec 31, 2024 | -19.22% |
| Sep 30, 2024 | 14.18% |
| Jun 30, 2024 | -148.34% |
| Mar 31, 2024 | 13.35% |
| Dec 31, 2023 | -26.46% |
| Sep 30, 2023 | 18.76% |
| Jun 30, 2023 | 1.74% |
| Mar 31, 2023 | 2.51% |
| Dec 31, 2022 | 34.51% |
| Sep 30, 2022 | 42.65% |
| Jun 30, 2022 | 34.41% |
| Mar 31, 2022 | 42.77% |
| Dec 31, 2021 | 46.15% |
| Sep 30, 2021 | 34.39% |
| Jun 30, 2021 | -41.86% |
| Mar 31, 2021 | 56.13% |
| Dec 31, 2020 | 33.98% |
| Sep 30, 2020 | 72.77% |
| Jun 30, 2020 | 83.84% |
| Mar 31, 2020 | 46.24% |
| Dec 31, 2019 | 48.94% |
| Sep 30, 2019 | 81.68% |
| Jun 30, 2019 | 161.77% |
| Mar 31, 2019 | 137.01% |
| Dec 31, 2018 | 162.03% |
| Sep 30, 2018 | 92.07% |
| Jun 30, 2018 | 63.39% |
| Mar 31, 2018 | 43.57% |
| Dec 31, 2017 | 43.25% |
| Sep 30, 2017 | 51.34% |
| Jun 30, 2017 | 47.00% |
| Mar 31, 2017 | 49.34% |
| Dec 31, 2016 | 190.72% |
| Sep 30, 2016 | 53.35% |
| Jun 30, 2016 | 123.36% |